Bristol-Myers Squibb Co (NYSE:BMY) stock is on the rise today, up 2.8% at $52.71 at last glance, after news that the biopharmaceutical company is acquiring Karuna (KRTX) for $14 billion. The deal, which will strengthen Bristol-Myers' neuroscience portfolio, is expected to close in the first half of 2024. KRTX is soaring after the news, up about 47%. Since the start of the year, BMY is down around 26%, recently hitting a Nov. 30 two-year low of $48.25, its lowest point since the start of Covid. The stock has ...

Nike Inc (NYSE:NKE) capped off earnings reports for 2023 with better-than-expected second-quarter profits of $1.03 per share, though revenue missed the mark. The retailer also slashed its annual forecast and noted it will cut hundreds of jobs to save $2 billion in the next three years, as consumers remain cautious and online sales lag, spurring more promotions.NKE was last seen down 10.3% at $109.87, following a downgrade from TD Cowen to "perform" from "outperform," and a price-target cut to $104 from $129 ...

The final quarterly reports of 2023 are trickling in, with chip name Micron Technology Inc (NASDAQ:MU) among the latest to enter the confessional. The company yesterday announced smaller-than-expected fiscal first-quarter losses of 95 cents per share, while revenue beat analysts' expectations. Micron's fiscal second-quarter revenue forecast came in above estimates as well, as demand for its flash storage and dynamic random access memory (DRAM) chips improves, and supplies near normal levels.At least 15 brok ...